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Stem cell cultures can be derived directly from early developing embryos and 
indirectly from differentiated cells by forced expression of pluripotency 
transcription factors. Pluripotency genes are routinely used to characterize 
mammalian stem cell cultures at the molecular level. However, such genes 
have remained unknown in lower vertebrates. This study made use of the 
laboratory fish medaka as a model, because of its unique embryonic stem (ES) 
cells and sequenced genome as useful experimental tools and genetic 
resource. Seven medaka pluripotency genes were identified by homology 
search and expression in vivo and in vitro. By RT-PCR analysis, they fall into 
three groups of expression pattern. Group I includes nanog and oct4 showing 
gonad-specific expression; Group II contains sall4 and zfp281 displaying 
gonad-preferential expression; Group III has klf4, ronin and tcf3 exhibiting 
expression also in several somatic tissues apart from the gonads. The 
transcripts of the seven genes are maternally supplied and persist at a high 
level during early embryogenesis. Early embryos and adult gonads were used 
to examine expression in stem cells and differentiated derivatives by in situ 
hybridization. Strikingly, nanog and oct4 are highly expressed in pluripotent 
blastomeres of 16-cell embryos. In the adult testis, nanog expression was 
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specific to spermatogonia, the germ stem cells, whereas tcf3 expression 
occurred in spermatogonia and differentiated cells. Most importantly, all the 
seven genes are pluripotency markers in vitro, because they showed high 
expression in undifferentiated ES cells but dramatic down-regulation upon 
differentiation. Therefore, these genes have conserved their 
pluripotency-specific expression in vitro from mammals to lower vertebrates. 
Furthermore, by using sequence differences between two medaka species: O. 
latipes and O. celebensis, I built a model to examine the timing of zygotic 
expression of six pluripotency genes by determining their expression from the 
paternal alleles. All those genes showed the onset of zygotic expression 
around the midblastula transition, suggesting their critical roles in early 
embryogenesis. Specifically, nanog and oct4 show earlier expression than the 
other remainder. Data obtained suggest the feasibility to study the hierarchical 
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CHAPTER 1: INTRODUCTION 
1.1 Stem cell 
1.1.1 Stem cell 
Stem cells, found in all multicellular organisms, can divide through mitosis and 
differentiate into diverse specialized cell types and can self renew to produce 
more stem cells. Stem cells are deﬁned based on three characteristics: they 
can undergo self-renewing cell divisions in which at least one of the daughter 
cells is a stem cell; they can give rise to multiple types of cell; they must be 
capable of repopulating a tissue in vivo (Verfaillie, 2009).  
Potency specifies the differentiation potential of the stem cell. Generally, there 
are five kinds of potency in stem cell. Totipotency is the ability of a single cell to 
divide and produce all the differentiated cells in an organism. 
Pluripotency refers to the potential of the stem cells to differentiate into any of 
the three germ layers: endoderm, mesoderm or ectoderm. However, 
pluripotent stem cells lack the potential to contribute to extraembryonic tissue. 
Multipotent stem cells can differentiate into a number of cells, but only those of 
a closely related family of cells. In addition, there are also oligopotent and 
unipotent cells. 
All mammals are derived from a single stem cell, which is known as the 
totipotent stem cell, such as zygote. During embryogenesis, stem cells 
undergo speciﬁcation to give rise to extraembryonic endoderm or cells of the 
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inner cell mass (ICM), which are pluripotent. Cells in the ICM then differentiate 
to three germ layers cells and ﬁnally to tissue speciﬁc stem cells. With each 
additional step of speciﬁcation, cells become more and more limited in their 
differentiation ability. These stem cells present in tissues of the three germ 
layers cannot generate cells of other tissues within the same germ layer or of 
the other germ layers, but the cells of that tissue. These cells are therefore 
multipotent (Verfaillie, 2009).  
1.1.2 Pluripotent stem cell 
In mammals, there are two broad types of stem cells: embryonic stem (ES) 
cells that are isolated from the ICM of blastocysts, and adult stem cells that 
are found in various tissues. ES cells have the ability to grow indeﬁnitely while 
maintaining pluripotency and the ability to differentiate into cells of all three 
germ layers (Evans and Kaufman, 1981).  
Pluripotent stem cell cultures can be derived from developing embryos and 
adult tissues. In particular, ES cells from early developing embryos are an 
excellent model for analyzing vertebrate development in vitro, and provide a 
versatile resource for induced differentiation into many desired cell types in 
large quantity for regenerative medicine. In mouse, ES cells have widely been 
used in gene targeting for generating knockout animals to study the functions 
of genes and to model human diseases (Wobus and Boheler, 2005). Since the 
production of first mouse ES cell lines in 1981 (Evans and Kaufman, 1981), 
numerous attempts have been made in ES cell derivation in different 
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vertebrate organisms (Munoz et al., 2009; Yi et al., 2010b). The success in the 
production of ES cells from the fish medaka (Hong et al., 1996) demonstrated 
that the ability for ES cell derivation is present from fish to mammals. In 1998, 
human ES cells were successfully established (Thomson et al., 1998). 
Previously, somatic cells can be reprogrammed by transferring their nuclear 
into oocytes (Wilmut et al., 1997) or by fusing the somatic cells with ES cells 
(Cowan et al., 2005; Tada et al., 2001). At present, induced pluripotent stem 
(iPS) cells can be generated from differentiated cells by introduced expression 
of reprogramming transcription factors (Takahashi et al., 2007; Takahashi and 
Yamanaka, 2006; Yu et al., 2007). 
Although interest in ES cell derivation has steadily been increasing and 
putative ES-like cells have been reported in several species (Hong N, 2011; Yi 
et al., 2010b), including short-term ES cell cultures capable of germline 
transmission in zebrafish(Ma et al., 2001a), stable lines of real ES cells have 
been limited to few organisms. One of the challenges is that there are no 
suitable molecular markers to monitor and regulate the pluripotency of putative 
ES cell cultures. 
1.2 Transcription factors 
Recent studies have established that mouse and human ES cells share a core 
transcriptional network consisting of Oct4, Nanog and Sox2 (Boyer et al., 
2005b; Loh et al., 2006b). Oct4 and Nanog, are essential regulators of early 




In 2006, Shinya Yamanaka demonstrated induction of pluripotent stem cells 
from mouse embryonic and adult ﬁbroblasts by introducing four factors, Oct4, 
Sox2, c-Myc and Klf4, under ES cell culture conditions (Takahashi and 
Yamanaka, 2006). The second year, his group reported the induction of 
pluripotent stem cells from adult human ﬁbroblasts using the same factors 
(Takahashi et al., 2007). The same year, James A. Thomson demonstrated 
that transcription factor Oct4, Sox2, Nanog and Lin28 are sufficient to 
reprogram human somatic cells to pluripotent stem cells that exhibit the 
essential characteristics of embryonic stem (ES) cells (Yu et al., 2007). In all 
those three studies, Oct4 is the key factor in induced pluripotent stem (iPS) 
cells. 
The mouse oct4 gene (also known as pou5f1) encodes a POU 
domain-containing and an octamer-binding protein and represents the 
prototype of pluripotency genes in mammals, because it is maternally supplied 
and expressed specifically throughout the totipotent cycle, including the inner 
cell mass (ICM), epiblast and primordial germ cells (PGCs) of early developing 
embryo and spermatogonia and oocytes (Pesce et al., 1998b). These 
embryonic and adult cells are all capable of producing stem cell cultures, in 
which quantitative Oct4 expression defines differentiation, dedifferentiation or 
self-renewal(Niwa et al., 2000b). Oct4-null embryos develop abnormal ICM 
cells which are not pluripotent and have a greater propensity to express 
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trophoblast markers and subsequently die at the peri-implantation stage of 
development (Nichols et al., 1998). When Oct4 expression is repressed in ES 
cells, cells lose their self-renewing state and spontaneously differentiate to the 
trophectodermal lineage (Nichols et al., 1998; Niwa et al., 2000a).  
Oct4 can act either to repress or to activate target gene transcription (Pesce 
and Schöler, 2001). It regulates expression of multiple genes (Saijoh et al., 
1996) via interactions with transcription factors present in pluripotent cells. For 
example, Oct4 can heterodimerize with Sox2, to affect the expression of 
several genes in mouse ES cells (Botquin et al., 1998).  
It was also reported that ES cells maintain Oct4 at an appropriate level in order 
to remain pluripotency. Either increase or decrease in expression of oct4 may 
induce ES cells to differentiate (Niwa et al., 2000a). ES cells with oct4 
downregulation differentiate to the trophectodermal lineage, while ES cells with 
an overexpression of oct4 tend to differentiate to multiple cell types (Niwa et al., 
2000a). 
1.2.2 Nanog 
Nanog is one of the transcription factors used in human somatic cells 
reprogramming (Yu et al., 2007).  
The gene nanog encodes a divergent protein that contains a homeobox. Its 
expression commences at the morula stage and later on occurs in the ICM, 
epiblast, PGCs and ES cell cultures, albeit its expression is absent in 
spermatogonia of the adult testis (Cavaleri and Scholer, 2003; Chambers et al., 
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2003). Nanog is one of the key regulators essential for the formation and 
maintenance of the ICM during mouse pre-implantation development and for 
self-renewal of pluripotent ES cells (Loh et al., 2006a)  
Embryos devoid of Nanog were unable to form epiblasts. (Mitsui et al., 2003) 
Such embryos seem to be able to initially give rise to the pluripotent cells, but 
these cells then immediately differentiate into the extraembryonic endoderm 
lineage (Loh et al., 2006a).  
Similar to oct4, nanog is downregulated upon ES cells differentiation and ES 
cells deficient in Nanog differentiate into cells of the extraembryonic endoderm 
lineage (Mitsui et al., 2003). Hence, it is commonly stated that both Nanog and 
Oct4 are critical in maintaining pluripotency in ES cells.  
However, contrary to previous findings, in other studies, Nanog-deficient ES 
cells were able to self-renew with Oct4 and Sox2 maintained (Chambers et al., 
2007). Therefore, such result gives rise to a conclusion that Nanog is essential 
for establishing pluripotency but is dispensable for the maintenance of 
self-renewal and pluripotency in ES cells (Heng and Ng, 2010). In the further 
study of the key transcription factor, namely Oct4, Nanog and Sox2, to 
maintain pluripotency in ES cells, researcher concluded that although each of 
these proteins has been described as a “master regulator” of pluripotency, only 
Oct4 appears absolutely essential, while both Sox2 and Nanog appear 
dispensable, at least in certain molecular contexts (Masui et al., 2007).  
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1.2.3 Other transcription factors 
Additional pluripotency genes have recently been described in mammals. 
These include klf4 encoding a Krüppel-like factor(Takahashi and Yamanaka, 
2006), ronin encoding the THAP domain containing 11 protein (Thap11) 
(Dejosez et al., 2008b), sall4 encoding the Sal-like protein 4 (Sall4) (Lim et al., 
2008; Tsubooka et al., 2009a), tcf3 (also called tcf7l1) encoding the T-cell 
transcription factor 3 (Cole et al., 2008a; Tam et al., 2008a) and zfp281 
encoding the zinc-finger protein 281(Wang et al., 2008a). These genes have 
been identified in mammalian ES cells. Their homologs/orthologs remain to be 
identified and characterized in lower vertebrates. 
1.2.3.1 Klf4 
Klf4, which is a zinc finger transcription factors, has a defining role in 
maintaining self-renewal in ES cells (Jiang et al., 2008). Overexpression of klf4 
can promote the self-renewal of ES cells (Hall et al., 2009). It was also shown 
that klf4 mRNA and protein expression were down-regulated during human ES 
cells differentiation (Chan et al., 2009).   
As a key factor in reprogramming, Klf4 functions as both a transcriptional 
activator and a repressor to regulate proliferation and differentiation of different 
cell types (Evans et al., 2007). Klf4 is the activator of the target gene nanog. 
Overexpression of klf4 up-regulates nanog promoter activity and the 
endogenous nanog protein expression in human ES cells. Knockdown of klf4 
or mutation of Klf4 binding motifs significantly down-regulated nanog promoter 
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activity (Chan et al., 2009).   
Genome-wide chromatin immunoprecipitation with microarray analysis 
demonstrates that the DNA binding profile of Klf4 overlaps with that of Oct4 
and Sox2 on promoters of genes specifically underlying establishment of iPS 
cells, suggesting transcriptional synergy among these factors (Sridharan et al., 
2009). Such finding was confirmed by other findings. A dominant negative 
mutant of Klf4 can compete with wild-type Klf4 to form defective 
Oct4/Sox2/Klf4 complexes and strongly inhibit reprogramming (Wei et al., 
2009). This finding reinforces the idea that direct interactions between Klf4, 
Oct4, and Sox2 are critical for somatic cell reprogramming (Wei et al., 2009).  
Another example was also provided: Klf4 was identified as a mediating factor 
that cooperates with Oct4 and Sox2 on the distal enhancer in activating the 
lefty1 promoter in ES cells (Nakatake et al., 2006).  
A recent study showed that introduction of single reprogramming factor, Klf4, 
can induce pluripotent stem cells from epistem cell (EpiSCs), a cell line that is 
from post-implantation epithelialized epiblast and unable to colonize the 
embryo even though they express the core pluripotency genes, oct4, sox2 and 
nanog. These EpiSC-derived induced pluripotent stem (Epi-iPS) cells 
activated expression of ES cell-specific transcripts including endogenous Klf4, 
and down-regulated markers of lineage specification (Guo et al., 2009).  
1.2.3.2 Ronin 
The protein Ronin possesses a Thap domain, which is associated with 
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sequence-specific DNA binding and epigenetic silencing of gene expression 
(Dejosez et al., 2008a). It is expressed primarily during the earliest stages of 
mouse embryonic development, and its deficiency in mouse produces 
peri-implantational lethality and defects in the ICM (Dejosez et al., 2008a). 
Meanwhile, ronin knockout ES cells were found to be nonviable. On the other 
hand, the overexpression of ronin can inhibit ES cells differentiation and allows 
ES cells to self-renew under conditions that normally suppress self-renewal 
(Heng and Ng, 2010). Interestingly, it was found that ectopic expression of 
ronin was able to partly compensate for oct4 knock-down in ES cells (Dejosez 
et al., 2008a). The authors also demonstrated that Ronin is a transcriptional 
repressor of multiple genes that are either directly or indirectly involved in 
differentiation (Dejosez et al., 2008a). Furthermore, it was shown that Ronin 
exerts its anti-differentiation effects through epigenetic silencing of gene 
expression (Dejosez et al., 2008a). In addition, ronin, like nanog, is also 
targeted by Caspase-3, a component of the cell death system that compels ES 
cells to exit their self-renewal phase and induces differentiation (Fujita et al., 
2008). Those findings reinforce that ronin is essential for the maintenance of 
pluripotent stem cells. 
1.2.3.3 Sall4 
A spalt family member, sall4, is required for the pluripotency of ES cells (Zhang 
et al., 2006). Previously, microarray studies revealed that sall4 and oct4 share 
similar expression patterns during early embryo development (Hamatani et al., 
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2004). Similarly to Oct4, a reduction in Sall4 levels in mouse ES cells results in 
respecification, under the appropriate culture conditions, of ES cells to the 
trophoblast lineage (Zhang et al., 2006). Also similar to oct4, in mouse ES cells, 
both overexpression and underexpression of Sall4 cause differentiation 
suggesting that ES cells maintain Sall4 at an appropriate level in order to 
remain pluripotency (Yang et al., 2010).  
Sall4 is important for early embryonic cell-fate decisions (Zhang et al., 2006). 
Sall4-null embryos died shortly after implantation (Tsubooka et al., 2009b).  
Sall4 plays positive roles in the generation of pluripotent stem cells from 
blastocysts and fibroblasts. Although ES-like cell lines could be established 
from Sall4-null blastocysts, the efficiency was much lower. The knockdown of 
sall4 significantly decreased the efficiency of iPS cell generation from mouse 
fibroblasts. Furthermore, retroviral transduction of sall4 significantly increased 
the efficiency of iPS cell generation in mouse and some human fibroblast lines 
(Tsubooka et al., 2009b).  
By using chromatin immunoprecipitation coupled to microarray hybridization, 
researchers have identified a total of 3,223 genes that were bound by the Sall4 
protein on duplicate assays with high confidence (Yang et al., 2008). Many of 
these genes have major functions in developmental and regulatory pathways 
(Yang et al., 2008). For example, Sall4 is a transcriptional activator of oct4, and 
has a critical role in the maintenance of ES cell pluripotency by modulating 
oct4 expression. Microinjection of sall4 small interfering (si) RNA into mouse 
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zygotes resulted in reduction of sall4 and oct4 mRNAs in pre-implantation 
embryos (Zhang et al., 2006).  
Although most studies generally showed the important role Sall4 plays in ES 
cells, Shunsuke Yuri stated that Sall4 does not contribute to the central 
machinery of the pluripotency. Instead it stabilizes ES cells by repressing 
aberrant trophectoderm gene expression (Yuri et al., 2009). Such statement 
provided a new point of view of the unique function of Sall4.  
1.2.3.4 Tcf3 
The Wnt signaling pathway is necessary both for maintaining undifferentiated 
stem cells and for directing their differentiation. In mouse ES cells, Wnt 
signaling preferentially maintains “stemness” under certain permissive 
conditions (Tam et al., 2008b) 
In searching how external signals connect to this regulatory circuitry to 
influence ES cell fate, Cole found that a terminal component of the Wnt 
pathway in ES cells, T-cell transcription factor-3 (Tcf3), co-occupies promoters 
throughout the genome in association with the pluripotency regulators Oct4 
and Nanog (Cole et al., 2008b). In mouse pre-implantation development 
embryos, Tcf3 expression is co-regulated with Oct4 and Nanog and becomes 
localized to the ICM of the blastocyst (Tam et al., 2008b).  
Up-regulation of nanog upon tcf3 depletion showed that Tcf3 acts to repress 
nanog under normal ES cell growth conditions (Pereira et al., 2006). 
Furthermore, it was also found that tcf3 depletion caused increased 
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expression of Oct4, Nanog, and other pluripotency factors and produced ES 
cells (Cole et al., 2008b). Comparing effects of tcf3 ablation with oct4 or nanog 
knockdown revealed that Tcf3 counteracted effects of both Nanog and Oct4 (Yi 
et al., 2008). However, Tcf3 is still important in maintaining pluripotency in ES 
cells. Through repressing pluripotency factors, Tcf3 prevents overactivation of 
transcriptional circuits, promoting pluripotent cell self-renewal (Yi et al., 2008). 
Meanwhile, by using a whole-genome approach, researchers found that Tcf3 
transcriptionally repressed many genes important for maintaining pluripotency 
and self-renewal, as well as those involved in lineage commitment and stem 
cell differentiation (Tam et al., 2008b). Thus, it was concluded that Wnt 
pathway, through Tcf3, brings developmental signals directly to the core 
regulatory circuitry of ES cells to influence the balance between pluripotency 
and differentiation (Cole et al., 2008b).  
1.2.3.5 Zfp281 
The zinc finger transcription factor Zfp281 was first implicated as a regulator of 
pluripotency in ES cells since it is expressed in undifferentiated ES cells and 
less in differentiated ES cells (Brandenberger et al., 2004). Then, Zfp281 was 
identified as a key component of the pluripotency regulatory network in a 
series of studies.  
Zfp281 was shown to activate nanog expression directly by binding to a site in 
the promoter (Wang et al., 2008b). Its binding sites for oct4, sox2 were also 
identified (Chen et al., 2008). Data in the analysis of protein interaction 
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networks in ES cells showed that Zfp281 physically interacts with Oct4, Sox2, 
and Nanog in regulating pluripotency (Wang et al., 2006).  
Through Chromatin immunoprecipitation, 2417 genes were identified to be 
direct targets by Zfp281, including several transcription factors that are known 
regulators of pluripotency (Wang et al., 2008b). Upon knockdown of zfp281, 
some of the Zfp281 target genes were activated, whereas others were 
repressed, suggesting that this transcription factor plays bifunctional roles in 
regulating gene expression within the network (Wang et al., 2008b). 
1.3 Medaka 
The medaka (Oryzias latipes) is well-suited for analyzing vertebrate 
development (Wittbrodt et al., 2002). This laboratory fish is used as a lower 
vertebrate model for stem cell biology (Hong N, 2011; Yi et al., 2010b). In this 
organism, a feeder-free culture system has been previously established that 
allowed for derivation of diploid ES cells(Hong et al., 1996; Hong et al., 1998) 
from midblastula embryos as the equivalent of the mammalian blastocysts, 
male germ stem cells from the adult testis (Hong et al., 2004a) and even 
haploid ES cells from gynogenetic embryos (Yi et al., 2009; Yi et al., 2010a). 
Most recently, it was demonstrated that in medaka early embryos even up to 
the 32-cell stage are capable of cell culture initiation (Li et al., 2011). In 
addition, the medaka genome has been fully sequenced and partially 
annotated (http://www.ensembl.org/index.html). The availability of sequence 
data and well-characterized stem cell lines makes medaka a unique model 
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organism to identify pluripotency genes in vivo and in vitro.  
1.4 Midblastula transition 
Early development of the embryo is directed by maternal gene products and 
has limited zygotic gene activity (O'Boyle et al., 2007). The cell divisions are 
characterized by synchrony, short phases and no cell motility (O'Boyle et al., 
2007). At the midblastula transition (MBT), a series of event happens: zygotic 
gene transcription is activated; the cell cycle lengthens; cell divisions lose their 
synchrony; cell motility begins (Newport and Kirschner, 1982a; Newport and 
Kirschner, 1982b). In the Xenopus embryos, the developmental changes 
termed MBT begin after the 12th cell division (Newport and Kirschner, 1982a). 
In zebraﬁsh, it begins at the 512-cell stage (cell cycle10), two cycles earlier 
than in Xenopus (Bree et al., 2005). Realization of critical nucleocytoplasmic 
ratio is thought to trigger the beginning of MBT (Aizawa et al., 2003). However, 
the mechanism of MBT has not been clariﬁed. 
Many of the genes that are first expressed at this stage will play critical roles in 
later events such as gastrulation and segmentation (Bree et al., 2005). So in 
order to obtain more insight of the function of certain gene, it is important to 
study the activation of zygotic transcription.  
There have been several studies to identify zygotically expressed genes in 
mouse. Those methods include large scale sequencing of expressed 
sequence tags from staged pre-implantation cDNA libraries (Ko et al., 2000), 
mRNA differential display (Ma et al., 2001b) and suppression subtractive 
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hybridization to prepare subtract zygotic cDNA libraries (Yao et al., 2003). 
However, in mouse embryo, the activation of zygotic gene expression occurs 
by the 2 cell stage (Aizawa et al., 2003). In addition, transcription of some 
genes even begins at 1 cell stage, such as hsp70.1 (Aizawa et al., 2003). 
Because of the fast zygotic activation, it is not possible to examine more 
details about the activation of genes at MBT. 
 
Aim 
Here I planned to identify several medaka pluripotency genes and examine 
their candidacy as pluripotency markers by analyzing RNA expression patterns 
in adult tissues, developing embryos and ES cell culture. Furthermore, I 
intended to build a model to examine the timing of zygotic expression of those 












CHAPTER 2: METHOD 
2.1 Animal stock and maintenance 
Work with fish followed the guidelines on the Care and Use of Animals for 
Scientific Purposes of the National Advisory Committee for Laboratory Animal 
Research in Singapore (permit number 27/09). Medaka was maintained under 
an artificial photoperiod of 14-h/10-h light/darkness at 26°C (Li et al., 2009). 
Adult fish are fed two to three times with artemia nauplii and dry food. Medaka 
strains HB32C and i1 were used for gene expression analysis by RT-PCR and 
in situ hybridization. HB32C is a wild-type pigmentation strain from which 
diploid ES cell lines MES1 were derived (Hong et al., 1996), whereas i1 is an 
albino strain from which haploid ES cell lines HX1 were generated (Yi et al., 
2009; Yi et al., 2010a).  
2.2 Expression pattern analysis 
2.2.1 Collection of adult tissue 
Adult male and female medaka fish were anaesthetized in ice-cold water for 2 
min. Dissection was then performed under a stereomicroscope (Leica MZ125). 
Tissues and organs were excised and collected into eppendorf tubes. Several 
adult tissues were selected in this experiment: brain, skin, heart, kidney, liver, 




2.2.2 Madaka embryo collection 
To obtain egg production in the laboratory, young medaka fish were kept after 
hatching under resting condition at high density in large containers for up to 8 
weeks. When females started spawning with about 5-10 eggs per day, males 
and females were separated for several days before they were brought 
together for the production of large numbers of eggs.  
When experiment started, the separated males and females were mixed 
together. Spawning took place within the first 30 min. The eggs stuck together 
through hairy filament and attached to the belly of female fish for several hours. 
Fertilized eggs were obtained by carefully scraping the egg clusters from 
females by hand. The clusters of eggs were transferred into a petri-dish with 
embryo rearing medium (ERM:17 mM NaCl, 0.4 mM KCl, 0.3 mM CaCl2·H2O, 
0.6mM MgSO4·7H2O, 1 ppm methylene blue). Single eggs were obtained 
either by rolling egg clusters on the petri-dish or by using needle to remove 
hairy filaments. Once the eggs were separated, the dead and injured embryos 
were removed.  
Single embryos were kept in 28°C until the desired stage of embryonic 
development. Embryos were staged according to Iwamatsu (Iwamatsu, 2004). 
Several developmental stages were chosen: 16-cell, morula, early blastula, 




2.2.3 Cell culture 
Maintenance and induced differentiation by embryoid body formation in 
suspension culture were done essentially as described for the diploid ES cell 
line MES1 (Hong et al., 1996) and the haploid ES cell line HX1 (Yi et al., 2009; 
Yi et al., 2010a). ES cells were cultured in medium ESM4 in gelatin-coated 
tissue culture plastic ware (BD biosciences, NJ) for undifferentiated growth. 
The exponentially growing cells were washed with 2ml PBS. After PBS was 
removed, 1 ml 1X trypsin-EDTA was added to trypsinize cells at room 
temperature for 5 min. The cells were spun down, and trypsin-EDTA was 
aspirated. Cells were resuspended in 1 ml ESM4 to form a single-cell 
suspension. Single cells were transferred into three to six wells of a 
gelatin-coated six-well plate or a 10-cm tissue culture dish.  
For induced differentiation, ES cells were trypsinized and separated into single 
cells and small aggregates, seeded into non-adherent bacteriological Petri 
dishes for suspension culture in growth factor-depleted ESM4 containing 
all-trans retinoic acid (Sigma, final 5 µM) for 7 days before harvest for RNA 
isolation. In suspension culture, cells formed aggregates of varying sizes 
(mostly 100~20 µm in diameter) at day 1 and subsequently developed into 
spherical embryoid bodies. The dishes of suspension cultures were gently 




2.2.4 Isolation of total RNA 
After adult tissue collection, samples were collected in eppendorf tubes 
respectively. For each developmental stage, approximately 20-30 medaka 
embryos were collected in eppendorf tubes. Excess water was removed with 
pipette. The tissues and embryos were homogenized in 1 ml of TRIZOL RNA 
isolation reagent (Invitrogen) with plastic pestles. 200 ml of chloroform was 
added in each tube. Each tube was inverted several times until the liquid was 
homogenized. The aqueous phase and organic phase were separated by 
centrifugation at 12000X g for 20 min at 4°C. The upper aqueous phase was 
transferred to a fresh RNase free tube. RNA was precipitated by 1 volume of 
isopropanol at room temperature for 30 min and centrifuged at 12000X g for 20 
min at 4°C. After centrifugation, supernatant was removed. The RNA pellet 
was washed with diethylpyrocarbonate (DEPC, Sigma) treated 70% ethanol 
(ethanol was dissolved by 0.1% DEPC treated water) and centrifuged at 
12000X g for 20 min at 4°C. Supernatant was removed as much as possible. 
The RNA pellet was air-dried and dissolved in 20 µl of 0.1% DEPC treated 
water. The quality of RNA was ascertained by gel electrophoresis, and the 
concentration was determined by Nanophotometer (WPA BioWave II+). The 





2.2.5 Sequence analysis and gene identification.  
BLAST searches were run against public databases by using BLASTN for 
nucleotide sequences, BLASTP for protein sequences and tBLASTN from 
protein queries to nucleotide sequences. Multiple sequence alignment was 
conducted by using the Vector NTI suite 11 (Invitrogen). Phylogenetic trees 
were constructed by the DNAMAN package (Lynnon BioSoft). Chromosomal 
locations were investigated by examining corresponding genomic sequences. 
Several medaka genes homologous/orthologous to the mammalian 
pluripotency genes have been previously described (Yi et al., 2009), including 
oct4, nanog, klf4, ronin, sall4, zfp281a and tcf3. However, the previous 
medaka tcf3 according to the genome annotation (ENSORLG00000004923 
and ENSORLG00000015259) was found to encode transcription factor E2A 
instead (Figure 1). A BLAST search by using the human tcf3 as a query 
against the medaka genome sequence (http://www.ensembl.org/index.html) 
led to the identification of a gene annotated as tcf3 (ENSORLG00000011813), 
to which more than 30 expressed sequence tags (http://blast.ncbi.nlm.nih.gov/) 







2.2.6 Reverse-Transcription Polymerase Chain Reaction (RT-PCR) 
2.2.6.1 DNase treatment 
In order to reduce the genomic DNA contamination, DNase I (Invitrogen) was 
used to treat the total RNA before cDNA synthesis.  
The following were added to an RNase-free, eppendorf tube on ice: 1 µg of 
RNA sample, 1 µl of 10X DNase I Reaction Buffer, 1 µl of DNase I (Amp Grade, 
1 U/µl) and DEPC-treated water to 10 µl. The tube was incubated at room 
temperature for 15 min. Then the DNase I was inactivated by 1 µl of 25 mM 
EDTA solution to the reaction mixture, followed by 10 min heating at 65°C. 
Now the total RNA was ready for cDNA synthesis.  
2.2.6.2 Reverse Transcription (RT) for cDNA synthesis  
Synthesis of cDNA templates was primed with oligo (dT)25 by using M-MLV 
reverse transcriptase (Invitrogen). A 20 µl reaction volume was used for 2 µg of 
total RNA. 1 µl of oligo (dT)25 (500 µg/ml), 1 µl of 10 mM dNTP Mix (10 mM 
each dATP, dGTP, dCTP and dTTP) and 2 µg of total RNA were added into a 
nuclease-free eppendorf tube. Sterile, distilled water was added to adjust the 
final volume to 12 µl. The mixture was heated to 65°C for 5 min and quickly 
chilled on ice thereafter. After brief centrifugation, 4 µl of 5X First-Strand Buffer, 
2 µl of 0.1 M dithiothreitol (DTT) and 1 µl of RNaseOUT™ Recombinant 
Ribonuclease Inhibitor (40 units/µl) were added into the reaction. The mixture 
was incubated for 2 min at 37 °C. 1 µl (200 units) of M-MLV reverse 
transcriptase was added at last, followed by 50 min incubation at 37°C. In 
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order to inactivate the reaction, the final product was heated at 70°C for 15 min. 
The final cDNA product was stored in -20°C for further use.  
2.2.6.3 Polymerase Chain Reaction (PCR)   
Standard PCR was performed in a 25 µl reaction using PTC-100 Thermal 
Cyclers (Bio-Rad). The following reaction components were added to a PCR 
tube for a final reaction volume of 25 µl: 2.5 µl of 10X Ex Taq Buffer(Mg2+plus), 
2 µl of dNTP Mix (2.5 mM each), 1 µl of amplification primer 1 (10 µM), 1 µl of 
amplification primer 2 (10 µM), 0.2 µl of Taq DNA polymerase (5 U/µl), 1 µl of 
cDNA (from first-strand reaction) and 17.3 µl of autoclaved, distilled water.  
The parameters for the amplification reaction were as below: 
94 ºC for 5 min (first denaturation); 
35 cycles of amplification process: 
94 ºC for 10 sec (denaturation), 
58 ºC for 20 sec (annealing), 
72 ºC for 60 sec (extension); 
 72 ºC for 7 min (final extension). 
PCR was run for 28 and 35 cycles for β-actin and other genes, respectively. 








Table 1 Genes and Primers used in RT-PCR for expression pattern analysis 
 
Gene Primer sequence size 
(bp)  Name Accession Forward primer Reverse primer 
nanog FJ436046 CTCCACATGTCCCCCCTTATC AGGATAGAATAGTCACATCAC 591 
oct4 NM_001104869 GCTTTCTTTGGCGTAAACTCGTC TCATCCTGTCAGGTGACCTACC 777 
klf4 ENSORLT00000007097 CATCCTCTCACCCAGATGC TCATAAGTGCCTCTTCATGTGG 447 
sall4 ENSORLG00000016130 ATGTCGAGGCGCAAACAAG AGCCACTTTAGCGTCAGGTATG 501 
tcf3 HQ705658 ATGCCTCAACTGAACGGAGG CTGCAGAGCTGGGAACATCC 433 
zfp281 ENSORLG00000005292 ATGAGTATTATCCAAGACAAGATAGGC TGTGTCCTTTTGTGTCGCTCC 854 
ronin ENSORLG00000008903 AACTGAGAAGCGACGAGTACTC CATTTTCTTTCTGAAACCAAC 302 
 
2.2.6.4 Agarose gel electrophoresis 
The PCR products were separated on 1% agarose gels. 1% agarose was 
prepared by melting 5 g of agarose (1st BASE) in 500 ml 1X TAE 
electrophoresis  running  buffer  (50X stock: 2M Tris-acetic acid, 10 mM 
EDTA, pH 8.0). 1% agarose was mixed with ethidium bromide. Agarose gel 
was prepared in tray mould using proper comb. The PCR products (25 μl) 
were thoroughly mixed with 5 μl of 6X loading buffer (0.25% bromophenol blue, 
0.25% xylene cyanol, and 60% glycerol), and a 10 μl aliquot was loaded into 
each well in the agarose gel. Electrophoresis was run at 100 V, 400 mA for 30 
min via PowerPac Basic Power Supply(Bio-Rad). The electrophoresis results 






Quantitative real time PCR analysis was carried out in triplicate on the IQ5 
system (BioRad). Each reaction consisted of 25 µl of 1X qPCR SuperMix 
(SYBR GreenER), 1 µl of forward primer (10 µM), 1 µl of reverse primer (10 
µM), 10 µl of template and 13 µl of DEPC-treated water. Primers are listed in 
Table 2. A standard 50-µl reaction size is provided; component volumes can be 
scaled as desired. 
The program of the real-time instrument was as below: 
50ºC for 2 min hold (UDG incubation); 
95ºC for 10 min hold (UDG inactivation and DNA polymerase activation); 
40 cycles of:  
  95ºC, 15 sec ,  
  60ºC, 60 sec ,  
Melting curve analysis. 
The reaction PCR plate was centrifuged briefly to make sure that all 
components were at the bottom of the plate. The PCR plate was sealed before 
it was placed in the preheated real-time instrument programmed as described 
above. When the reaction stopped, the data were collected and analyzed. 
 
Table 2 Genes and Primers used in qPCR 
 
Gene Primer sequence size 
(bp)  Name Forward primer Reverse primer 
nanog CACAATGCTGTCCAATGAGGTAG GCCAGGATAGAATAGTCACATCAC  232 
oct4 TGTCTCCCATCATCCTGTCA AGTGCGTCTCCACTCAACCT  174 
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2.3 Molecular cloning 
I chose gene nanog, oct4 and tcf3 to do in situ hybridization. The PCR 
products of medaka nanog, oct4 and tcf3 were used.  
2.3.1 Recovery of PCR products from agarose gel 
The PCR products were excised from the gel under UV light and extracted by 
the QIAquick Gel Extraction Kit (QIAGEN). Briefly, for every 100 mg excised 
gel, 300 μl of buffer QG was added. Gel was heated at 50°C until the gel slice 
has completely dissolved. After that, 100 μl of isopropanol was added into the 
sample. The sample was applied to the QIAquick column and centrifuged for 1 
min. The flowthrough was discarded, and the column was washed with buffer 
PE. Centrifugation was carried out for 1 min at 17900 x g (13000 rpm). To 
remove residual wash buffer, the QIAquick column was centrifuged once more 
for 2 min. PCR products were eluted from the column with 30 μl of buffer EB. 
The concentration of the final product was determined by Nanophotometer 
(WPA BioWave II+).  
2.3.2 TA cloning 
Purified PCR products were cloned into pGEM-T Easy vectors (Promega). The 
ligation reaction consisted of 2X ligation reaction buffer, pGEM-T Easy vector 
(50 ng), 1-2 µl T4 ligase (3U/ul) and insert. The insert : vector molar ratio was 
3 : 1. The total volume of the ligation reaction was adjusted to 10ul or 20ul 
according to the volume of insert and vector.  
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2.3.3 Preparation of competent cells (RbCl method) 
Stock of E. coli was streaked onto LB plates and incubated overnight at 37° C.  
A single colony was inoculated into 3 ml of LB broth and incubated overnight at 
37° C. The next day, 1 ml of such culture was inoculated into 100 ml of LB 
broth in a 250 ml flask and incubated at 37°C for 2-3 h until OD600 of the 
bacterial culture got to 0.35-0.4. The bacterial culture was transferred into a 
50ml falcon tube and chilled on ice for 15min. The bacteria were spun down by 
centrifugation at 2700 rpm, 4°C for 20 min. From this step onwards, remaining 
steps were carried out on ice. The supernatant was discarded, and 20 ml 
ice-cold sterile TfbI solution (30 mM KAc, 100 mM RbCl, 10 mM CaCl2.2H2O, 
50 mM MnCl2.4H2O, 15% v/v glycerol) was added in falcon tube. The bacterial 
pellet was resuspended gentlely in the TfbI solution and chilled on ice for 30 
min. Centrifugation was carried out again in order to pellet the bacteria. After 
supernatant was removed, 2 ml ice-cold sterile TfbII solution (10 mM MOPS, 
75 mM CaCl2, 10 mM RbCl, 15% v/v glycerol) was used to resuspend the 
bacteria. The suspension was dispensed into 100 μl aliquots in 1.5 ml 
eppendorf tubes and frozen in liquid nitrogen before storing at -80° C. 
Efficiency of competent cells was tested before they were applied in the 
experiment. 100 pg, 10 pg and 0 pg plasmids were transformed into 100 μl of 
those cells respectively. The efficiency was calculated according to: number of 




2.3.4 Transformation of competent cells 
Competent cells were thawed on ice for 15 min. Meanwhile, ligation products 
were also chilled on ice. 5 μl of ligation product was added to the cells, 
followed by 30 min incubation on ice. The eppendorf tube containing 
competent cells was transferred quickly from ice to 42° C water bath for 90 s 
and then transferred back immediately on ice. 1 ml of LB medium was added 
into the tube, and the bacteria were incubated at 37°C for 40 min for recovery. 
Bacteria were spun down by centrifugation at 5000 rpm for 1 min. After the 
supernatant was removed, the bacteria were resuspended in 100 μl of LB 
medium. The LB ampicillin (100 μg/ml) plate was pre-coated with 50 μl of X-gal 
(2% 5-bromo-4-chloro-3-20 indolyl-β-D-galactoside) and IPTG 
(isopropylthio-β-D-galactoside). The bacterial suspension was then spread on 
the plate. The plate was incubated for 16 h at 37°C. 
2.3.5 Minipreps of plasmids (Alkaline lysis method) 
Single white colonies were inoculated into 3 ml LB+ ampicillin (100 μg/ml) 
medium in 15 ml Falcon snap cap tubes. The bacteria were incubated 
overnight at 37°C. 1.5 ml of bacterial culture was transferred into a 1.5 ml 
eppendorf tube and centrifuged at 6000 rpm for 5 min. The supernatant was 
discarded, and the pellet was resuspended in 100 μl of ice-cold buffer P1 (50 
mM glucose, 25 mM Tris-Cl pH 8.0, 10 mM EDTA pH 8.0, 100 μg/ml RNase A) 
by vortex. 200 μl of freshly-prepared alkaline lysis buffer P2 (0.2 N NaOH, 1% 
w/v SDS) was added, followed by gentle inversions of the tube. 150 μl of 
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ice-cold buffer P3 (5 M potassium acetate, 5 M acetic acid) was quickly added 
and gently mixed with the bacterial lysate to stop lysis reaction. After 50 μl of 
chloroform was added, the eppendorf tube was put on ice for more than 5 min. 
Then, the bacterial lysate was centrifuged at 15000 rpm for 5 min at 4°C. The 
supernatant was transferred into a new eppendorf tube. An equal volume of 
100% isopropanol was added to precipitate the plasmid DNA. The mixture was 
incubated on ice for 10 min and centrifuged at 15000 rpm for 5 min at 4°C. The 
supernatant was removed, and the white pellet was washed by 500 μl of 70% 
ethanol. After one more centrifugation, ethanol was discarded, leaving the 
pellet. The plasmid pellet was air-dried and dissolved in 50 μl of TE+ RNase 
buffer (10 mM Tris-Cl, 1 mM EDTA, pH 7.4, 20 μg/ml RNAse A). 
2.3.6 Plasmid screening by restriction enzyme digestion 
To identify whether the right insert was cloned in the plasmid, test digestion 
was performed with appropriate restriction enzymes. Normally, EcoRI 
(Promega) was used. The digestion reaction consisted of 10X buffer, plasmid 
and enzyme (10 U/μl). The amount of DNA and enzyme was determined 
according to the principle that 1 unit enzyme digests 1 μl of DNA at 37 °C for 1 
h. The total volume of the digestion reaction was adjusted to 10 or 20 μl. The 
reaction was incubated at 37 °C for more than 1 h. Finally the digested 
products were evaluated through gel electrophoresis to check the released 




Desired plasmid clones were sequenced by the BigDye Terminator V3.0 Cycle 
Sequencing Kit (Applied Biosystems). 
Total volume of 5 µl was used in the sequencing reactions. For each reaction, 
the following reagents were added to a separate 0.2 ml PCR tube: 2 µl of 
Terminator Ready Reaction Mix (Big Dye ABI), 1 µl of M13 forward (or reverse) 
primer (10 µM) and 2 µl of template (pGEM plasmid). PCR tubes were placed 
in the PTC-100 Thermal Cyclers (Bio-Rad) and subjected to the program as 
follows:  
95ºC for 5 min; 
25 cycles of:  
  95ºC, 10 sec,  
      50ºC, 10 sec,  
      60ºC, 2.5 min. 
Extension products were purified by ethanol precipitation. In each tube of 
product, 2.5 volume of 100% ethanol and 0.1 volume of sodium acetate (3 M, 
pH 4.6) were added and mixed gently. The tubes were left at room temperature 
for >15 min (and < 24 hrs) to precipitate products. Thereafter, the precipitate 
was spun down for a minimum of 20 min at maximum speed. The supernatant 
was discarded. The final product was washed by 70% ethanol and centrifuged 
as before for 5 min at maximum speed. Sample was air-dried for 15 min and 
redissolved in 15 µl of Hidi formamide. The sample was sequenced by using 
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the Applied Biosystems 3130xl (Applied Biosystems, MA). 
2.3.8 Midiprep of plasmids 
Bacterial cultures with successful insertions were inoculated into 50 ml of 
LB+ampicillin medium and incubated overnight at 37°C. Midiprep was 
performed with Nucleobond AX kit (Macherey-Nagel). Plasmid concentration 
was determined by Nanophotometer (WPA BioWave II+). 
2.4 In situ hybridization 
All solutions and buffers used from this point were prepared with DEPC-treated 
water, and reactions were all performed under RNase-free conditions.  
2.4.1 Synthesis of RNA probes 
As described, the amplified products of medaka nanog, oct4 and tcf3 were 
cloned into pGEM-T. The plasmid was linearized with ApaI for the synthesis of 
RNA probes.  
The linearized plasmid DNA was purified by phenol/chloroform extraction. 0.1 
volume of Sodium Acetate was added to the digestion product. The template 
DNA was extracted once with a equal volume of phenol and 
chloroform/isoamyl alcohol(IAA)(24:1), and then twice more with 
chloroform/IAA. 2 volume of ethanol was used to precipitate the DNA, and the 
template was left at -20°C for approximately 1 h. The DNA pellet was spun 
down, washed with 70% ethanol and redissolved in TE (10 mM Tris-Cl, 1 mM 
EDTA, pH 7.4). The concentration of linearized product was determined by 
Nanophotometer (WPA BioWave II+). 
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The purified linearized plasmid was used as a template for synthesis of RNA 
probes labelled with digoxigenin (DIG) or fluorescein isothiocyanate (FITC). 
The nanog and tcf3 probes were labeled with DIG while the oct4 probes were 
labeled with FITC. The synthesis reaction was performed at 37°C for 2 h in a 
total volume of 20 μl. The whole reaction consisted of 1 μg of template DNA, 2 
μl of 100 mM dithiothreitol(DTT), 2 μl of 10 mM NTP mix with 
Dig-UTP/Fluorescein-UTP (Roche), 0.5 μl of RNase inhibitor, 4 μl of 5X 
transcription buffer, 1 μl of T7 (Sp6) RNA polymerase, and DEPC-treated water. 
Following the reaction, 1 μl of Turbo RNase-free DNase (Ambion) was added 
to digest the DNA template at 37°C for 15 min. After digestion, probe was 
precipitated by 30 μl RNasefree water and 30 μl Lithium Chloride Precipitation 
Solution (7.5 M lithium chloride, 50 mM EDTA, pH 8.0), washed with 70% 
ethanol, air-dried and dissolved in 25 μl DEPC-treated water. At last the probe 
was quantified, diluted to a final concentration of 1ng/μl in hybridization buffer 
(50% formamide (Sigma), 5xSSC, 50 μg/ml heparin, 0.1%Tween20, 5 mg/ml 
torula RNA, pH 6.0-6.5) and examined by normal agarose gel running.  
2.4.2 Whole mount in situ hybridization (WISH) 
Medaka ovary was fixed in 4 % PFA (paraformamide) / 0.85 X PTW (prepare 
16% PFA as stock) for 48 h at 4°C, washed three times with PBS and stored in 
50% formamide/2 X SSC (pH 6.5) at -20°C. After the outer layer membrane 
was removed, the ovary was transferred into 100% methanol and stored in 
-20°C for at least one overnight. When hybridization was started, the ovary 
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was transferred into 24 or 48 well cell culture dish, rehydrated through a series 
of methanol dilutions: 75% MeOH (methanol)/PTW (0.1% tween in 0.85 X 
PBS), 50% MeOH/PTW, 25% MeOH/PTW and rinsed 3 times, each for 5min, 
in 1XPTW. Following rehydration, the ovary was digested by Proteinase K 
(PTK: 10 μg/ml in PTW, prepare 20 mg/ml for stock; Roche) at room 
temperature for following probe penetration. After PTK digestion, the ovary 
was rinsed twice in freshly prepared 2mg/ml glycine/PTW, re-fixed in 4% 
PFA/PTW for 20 min and washed 5 times in PTW.  
For pre-hybridization, the ovary was rinsed in hybridization buffer and 
incubated at 68°C for 2 h. The probe was diluted in 200 μl hybridization buffer 
to a final concentration of 1-5 ng/μl and denatured at 80°C for 10 min, followed 
by 2 min incubation in ice water bath. After the pre-hybridization buffer was 
removed, the denatured hybridization probe was quickly added to the sample. 
Hybridization was performed at 68°C in a water bath for 16 h with shaking. On 
the second day, the ovary was washed in 50% formamide/2xSSCT (diluted 
from 20 X SSC, pH 7.0, 0.1 % Tween) at 68°C for two times, each for 30 min, 
2xSSCT at 68°C for 30 min and 0.2xSSCT at 68°C for two times, each for 30 
min. After hybridization, RNase free condition is not required. Subsequently, 
the ovary was washed twice with PTW at room temperature and blocked with 5% 
sheep serum/PTW at room temperature for 1 hour on a shaker. After blocking 
solution was removed, the ovary was incubated with anti-Dig-AP Fab 
fragments (Roche) at a 1: 2500 dilution in 5% sheep serum/PTW at room 
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temperature. The ovary was washed in PTW 6 times, each for 15 min and 
washed again in TBST (100 mM TrisCl, pH 9.5, 100 mM NaCl, 0.1%Tween-20) 
twice, each for 2 min. Then the ovary was equilibrated for 5 min in staining 
buffer NTMT (100 mM TrisCl, pH 9.5, 100 mM NaCl, 50 mM MgCl2, 
0.1%Tween20, prepared freshly) and incubated with NTMT containing BCIP 
(final 175μg/ml, stock: 50 mg/ml in 100% DMF) and NBT (final 337.5μg/ml, 
stock: 75 mg/ml in 70% DMF/H2O) in darkness without shaking at 4°C from 
several hours to days until signals appeared. The staining process was 
stopped by washing with PTW. For immediately photography, the ovary was 
rinsed in 87% glycerol overnight. 
2.4.3 Section in situ hybridization (SISH) 
The tissue testis was obtained as described. The tissues were fixed in 4% PFA 
overnight at 4°C. After fixation, the tissues were dehydrated by rinsing in 20% 
sucrose/PBS overnight, 30% sucrose/PBS for 2 h, 1:1 of 30% sucrose:O.C.T 
(embedding medium) for 30 min and embedded in O.C.T with liquid nitrogen in 
a special mould under stereomicroscope. Embedded tissues were kept below 
-20°C and fixed to a supporting base for cryostat (CM1850, Leica). Section 
was done at 4 µm for testis. The sections were collected onto pre-cleaned 
slides (Fisher scientific) and stored at -80°C. For hybridization, the sections 
were incubated on a 42°C heating block for 30 min and directly rinsed in 
hybridization buffer. The following steps were similar to WISH.  
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2.4.4 Fluorescent in situ hybridization(FISH) 
For embryo FISH, 16-cell stage embryos were obtained as described. The 
fixation of embryos and hybridization were similar to WISH. After 
post-hybridization wash, the hybridized embryos were blocked and incubated 
with anti-fluorescein POD for 4 h at room temperature followed by six washes 
for 20 min each with PBS. These embryos were then incubated in TSA plus 
fluorescein solution for 60 min, rinsed orderly in 30%, 50%, 75% and 100% 
methanol/PBS each for 5 min and then incubated in 1% H2O2 in 100% 
methanol for 30 min. After this incubation, these embryos were rinsed orderly 
in 75%, 50% and 30% methanol/PBS and washed with PBS 3 times, each for 
10 min. For second probe detection, the embryos were blocked again and 
incubated with anti-DIG POD for 4 h at room temperature followed by 6 
washes, each for 20 min, with PBS. These embryos were then incubated in 
TSA plus Cy3 solution for 60 min followed by 3 washes with PBST. Finally, the 
embryos were deyolked, stained with DAPI and mounted with anti-fade 
reagent for photography. 
For testicular section FISH, the tissue processing and hybridization were 
similar to SISH. After post-hybridization wash, the probe detection was 
performed with the same method as that in embryo FISH. Instead of two 
different antibodies for two probe detection, only anti-DIG POD was used to 
detect single tcf3 probe. The sections were finally stained with DAPI and 
mounted with anti-fade reagent for photography. 
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2.4.5 Microscopy and photography 
Observation and photography on Leica MZFIII stereo microscope, Zeiss 
Axiovertinvert 2 invert microscope and Axiovert 200 upright microscope with a 
Zeiss AxioCam MRc5 digital camera (Zeiss Corp., Germany) were as 
described previously (Yi et al., 2009). 
2.5 Zygotic expression examination 
In order to examine the zygotic expression of pluripotency genes, I made use 
of the sequence difference between two species, O. latipes and O. celebensis. 
F1 embryos obtained by crossing O. celebensis with O. latipes were used. 
Since the F1 embryos have DNA from both parents, the paternal transcripts 
can be detected by RT-PCR analysis using paternal-species-specific primer, 
while maternal transcripts cannot be detected. Therefore zygotic expression 
can be examined. 
2.5.1 Gene cloning in O. celebensis 
The ovary was obtained as described in the collection of adult tissue. Total 
RNA was isolated by using the Trizol Reagent (Invitrogen). Synthesis of cDNA 
templates was primed with oligo (dT)25 by using M-MLV reverse transcriptase 
(Invitrogen). 
In order to amplify the fragment of the seven genes in O. celebensis, the 
primers in Table 3 were used in RT-PCR. PCR was run in a 25 µl volume 
containing 10 ng of cDNA reaction for 37 cycles (20 s at 94ºC, 20 s at 58ºC 
and 120 s at 72ºC). The PCR products were separated on 1% agarose gels 
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and documented with a bioimaging system (Synoptics). 
The PCR products were purified by QIAquick Gel Extraction Kit (QIAGEN) and 
cloned into pGEM-T Easy vectors (Promega). The insert was sequenced by 
the Applied Biosystems 3130xl (Applied Biosystems). 
 
Table 3 Genes and Primers used for gene cloning 
 
Gene Primer sequence 
Forward primer Reverse primer 
nanog ATGGCGGAGTGGAAAACTCAGGTC TCATTGGACAGCATTGTGCAAAATG 
oct4 ATGTCTGACAGGCCGCACAGCC TCATCCTGTCAGGTGACCTACC 
klf4 ATGGCGTTAGGCGGAACAC TCATAAGTGCCTCTTCATGTGGA 
sall4 ATTGCACTAAAAGCCAGCAGG TCTCCAGGCAGTCCACCATC 
tcf3 ATGCCTCAACTGAACGGAGG AGGGCTGCCTGATGGAAC 
zfp281 ATGAGTATTATCCAAGACAAGATAGGC TGACTTGTCATGCTTGAGATCCAG 




2.5.2 Sequence analysis and species specific primer design 
Sequence alignment between O. latipes and O. celebensis was carried out in 
Vector NTI.  The regions on the gene fragments with obvious sequence 
differences were chosen to design species specific primers. The 






Table 4 Genes and Primers used in RT-PCR for examining zygotic expression 
 
Gene Primer sequence 
Name species Forward primer Reverse primer 
nanog Oc GTTTCAGAACCGTAGGATGAAGC  AGGTAGAACGCCAAGTTCTGC 
oct4 Oc ATATTTCGGCGCAAACGCAG  TCATCCTGTCAGGTGACCTACC 
klf4 Oc GAAGGAGGAGCTGTTCCACC  GTACTCTCCTGCATCCATTGCC 
sall4 Oc GAGATGTTGAGCCTCCCGC  CCAGTCCCATCTCTTTGCCA 
tcf3 Oc GCCTCTCCTGGATGTCCCAG  CTCTGGCGAGAGGTGCGAT 
ronin Oc CTTCCAGCCCACCACAGGT TTGAGTTCCTCCTCGATGCTGAT 
nanog Ol GTTTCAGAACCGTAGGATGAAGC  AGATAGAAGGCCAGGTTGTGT 
oct4 Ol TTTCTTTGGCGTAAACTCGT  TCATCCTGTCAGGTGACCTACC 
Oc, O. celebensis; Ol, O. latipes 
2.5.3 In vitro fertilization 
O. latipes female fish that produced many good eggs were isolated. On day of 
experiment, O. latipes female and O. celebensis male fish were anaesthetized 
in the ice-cold water, and surface-dried by a paper towel. The fish were placed 
in a 10 cm plastic petri-dish and gonads were individually dissected. Ovaries 
were put in medaka oocyte medium(MOM; 9.8 g/L medium M199 and 
antibiotics (Invitrogen), pH 8.0.) in a 60 mm Petri dish, and mature oocytes 
were released and transferred into 5 ml of MOM in a 35mm dish at room 
temperature. Work with testis and sperm preparation was done in separate 
places and with different sets of forceps and tweezers. A single testis was used 
for up to 40 eggs. The testis of adult O. celebensis was isolated, rinsed in PBS 
(137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4, pH7.4), 
transferred into a drop of 100-μl cold PBS in a dish on ice, and manually 
dissociated with a pair of forceps into single cells and small aggregates. The 
preparation was transferred into a 1.5 ml eppendorf tube and allowed to settle 
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down for 5 min on ice. The top supernatant rich in single sperm (20-50 μl) was 
immediately added to 10-40 eggs in 0.5 ml of MOM for activation. After 
incubation for 2 min in darkness, the activated eggs were rinsed and incubated 
at 28ºC in embryo rearing medium. Successful in vitro fertilization was 
examined by two criteria. Firstly, fertilized eggs will become transparent while 
unfertilized eggs will remain opaque. Second, successfully fertilized embryos 
will begin development, therefore embryogenesis can be observed according 
to the time line of embryo development. On the other hand, some unfertilized 
eggs will stop their development at one-cell stage. The hybrid embryos were 
kept in 28ºC. Embryos were staged according to Iwamatsu(Iwamatsu, 2004). 
Several developmental stages are chosen: 16-cell (stage 6), early morula 
(stage 8), late morula (stage 9), early blastula (stage 10) and late blastula 
(stage 11). For each stage, 8-10 embryos were collected. The same work was 
also performed for O. latipes male and O. celebensis female fish. 
2.5.4 Zygotic expression examination 
As described, total RNA of hybrid embryos was isolated by the Trizol Reagent 
(Invitrogen). Synthesis of cDNA templates was primed with oligo (dT)25 by 
using M-MLV reverse transcriptase (Invitrogen). PCR was run in a 25 μl 
volume containing 10 ng of cDNA reaction for 30 and 35 cycles (20 s at 94ºC, 
20 s at 58ºC and 60 s at 72ºC) for β-actin and other genes, respectively. 
Primers are listed in Table 4. The PCR products were separated on 1% 
agarose gels and documented by a bioimaging system (Synoptics).  
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CHAPTER 3: RESULTS 
3.1 Gene identification 
I adopted a homology approach to identify medaka pluripotency genes by 
taking advantage of genome sequence data. Through BLAST searches 
against public database, putative homologs/orthologs of several mammalian 
pluripotency genes including nanog, oct4, klf4, sall4, zfp281, ronin and tcf3 
have previously been identified (Yi et al., 2009). In literature and several 
annotated genomes, tcf3 (also tcf7l1) is confused with e2a (also called e12 or 
e47) encoding transcription factor E2A (E2A immunoglobulin enhancer binding 
factor). The improvement in the genome sequence and the availability of more 
cDNA sequences led to revisit gene identification in medaka. Extensive 
reciprocal BLAST searches and sequence alignments revealed that the two 
















Figure 1. Sequence comparison of E2A (E12/E47) proteins on alignment. Species 
names and gene accession numbers are given at the end of alignment. The two medaka 
e2a genes, e2a1 (HQ709443) and e2a2 (HQ709444), have been submitted to GenBank. 
The activation domain 1 (AD1), the loop-helix activation domain 2 (LH-AD2) and the 





Meanwhile the new tcf3 was identified. However, only single tcf3 gene is found 
in the medaka genome, while two tcf3 genes, namely tcf3a and tcf3b, exist in 
zebrafish(Dorsky et al., 2003; Kim et al., 2000). To see whether the medaka 
tcf3 is homologous or orthologous to the mammalian gene, I compared its 
protein sequence and its chromosome location. On sequence alignment, the 
medaka Tcf3 protein shows a high overall conservation and has a beta-catenin 
binding domain and a class-I HMG box (Figure 2A). By pairwise comparison, 
the medaka Tcf3 is 65.7% and 67.5% identical to the mouse and human Tcf3 
protein, respectively (Figure 2A). On a phylogenetic tree, the medaka Tcf3 
clusters with known zebrafish Tcf3 protein, while the mouse and human Tcf3 
proteins form a second cluster (Figure 2B). More importantly, medaka tcf3 
exhibits a syntenic relationship to its human counterpart (Figure 2C). These 
data suggest that the medaka tcf3 identified in this study is a homolog of the 
















Figure 2. Phylogenetic comparison of Tcf3/Tcf7l1 proteins. (A) Sequence alignment. 
At the end of the alignment are species, gene accession numbers and amino acid 
identity values. The β-catenin binding domain and high mobility group (HMG) box 
are highlighted in frame. (B) Phylogenetic tree of Tcf3/TCF7l1 proteins. (C) 
Chromosome location of the tcf3/tcf7l1 gene in human and medaka. Chromosomal 






3.2 Expression pattern analysis 
3.2.1 RT-PCR analysis of expression in tissues 
There is a set of seven medaka genes in this study. I carried out sequence 
analysis using CDS and genomic sequence of these pluripotency genes, to 
identify exon and intron within the genes. Based on the sequence analysis 
results, intron-spanning gene specific primers were designed. By using 
primers listed in Table 1, RT-PCR analysis was performed to analyze their 
expression patterns in eight representative tissues: brain, skin, heart, kidney, 
liver, gut, testis and ovary. According to expression patterns in adult tissues, 
the seven genes fall into three groups (Figure 3): Group I contains nanog and 
oct4, which show gonad-specific expression; Group II comprises sall4 and 
zfp281, which display high expression in the gonads and detectable 
expression in 1 or 2 somatic tissues; Group III consists of klf4, ronin and tcf3, 
which exhibit wide expression at variable levels in 6 to 7 tissues. The 












Figure 3. RT-PCR analysis of RNA expression in adult tissues 
 
Table 5 Summary of RNA expression in medaka adult tissues 
 
Gene brain skin heart kidney liver gut testis ovary 
Oct4 - - - - - - ++ +++ 
Nanog - - - - - - ++ +++ 
klf4 + + +   + ++++ + 
sall4 + + - + +++  + ++ 
tcf3 +++ ++ +++ +++ + ++ +++ ++ 
zfp281a + - ++ - - - ++ +++ 
ronin ++ + ++ ++ ++ + +++ +++ 
Relative levels of expression are indicated by -, +, ++ and +++ for barely detectable, faintly 




3.2.2  RT-PCR analysis of expression in embryos 
RT-PCR analysis was performed to analyze their expression patterns in seven 
critical stages of embryos: 16-cell, morula, early blastula, late blastula, pre-mid 
gastrula, 34 somite and prehatch. The transcripts of the seven genes were 
easily detected in developing embryos ranging from cleavages to the late 
blastula stage (Figure 4), suggesting that their RNAs are maternally supplied 
since zygotic transcription in medaka does not occur until the midblastula 
transition (Aizawa et al., 2003). When embryonic development proceeds 
through gastrulation to the prehatching stage, differences in RNA level became 
apparent among the genes: nanog and oct4 sharply declined and ultimately 
became undetectable; sall4, zfp281 and klf4 exhibited a dramatic decrease, 
whereas ronin and tcf3 displayed little change. Since cell lineage restriction 
and differentiation occurs during and after gastrulation, expression patterns 
shown by the RT-PCR analysis suggest that nanog and oct4 appear to be 
expressed mainly in pluripotent cells of developing embryos, while the other 










Figure 4. RT-PCR analysis of RNA expression in embryos. 
 
3.2.3 in vivo expression in embryos and the adult gonad 
In the mouse, the totipotent cycle begins with the zygote, proceeds through a 
series of transient structures (morula, inner cell mass and epiblast) and ends 
with the germline, which establishes PGCs and ultimately produces eggs and 
sperm in the adult gonads, the ovary in the female and the testis in the 
male(Pesce et al., 1998a). All the transient embryonic structures and PGCs 
have the potential to produce pluripotent stem cell cultures. Even adult 
spermatogonia, the male germ stem cells, are also capable of generating stem 
cell cultures in fish (Hong et al., 2004a) and mouse (Guan et al., 2006). 
Therefore, I made use of early embryos and adult gonads as in vivo systems to 
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study gene expression in stem cells and their differentiated derivatives.  
Through the two color fluorescent in situ hybridization procedure (Liu et al., 
2009; Xu et al., 2009), the transcripts of both nanog and oct4 were found to be 
present in blastomeres of the 16-cell staged embryos (Figure 5A-C), in 
accordance with a high level of their RNAs by RT-PCR analysis (Figure 4). It 
was also observed that a majority (75%, n = 12) of 16-cell embryos exhibited a 
significantly more intense signal for both nanog and oct4 in the four inside 
blastomeres compared to the 12 peripheral blastomeres (Figure 5A-C). 
Because of the early expression of both nanog and oct4, the expression of the 
two genes is associated with embryonic pluripotency. 
In medaka, the female produces eggs every day, and the mature ovary 
comprises a small number of oogonia and oocytes at ten ontogenic stages 
(Iwamatsu et al., 1988). The adult medaka testis is composed of 
spermatogonia and differentiating spermatogenic cells in the seminiferous 
cysts. Spermatogonia are single cells or small clusters and seminiferous cysts 
comprise germ cells at various stages of spermatogenesis. Spermatogenesis 
proceeds synchronously in each cyst through primary spermatocytes (meiosis 
I), secondary spermatocytes (meiosis II), spermatids (meiosis completion) and 
sperm (terminally morphological differentiation). The testis is a highly ordered 
organ. Spermatogonia are located at the outmost periphery. The cysts 
consisting of germ cells at the most advanced stages of development reside 
closer to the efferent duct, which is in the central region. The unique 
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architecture and bipolarity of spermatogenesis make possible the 
unambiguous distinction of stem cells and of their progressive differentiation. 
I chose nanog as a representative of group-I genes for chemical in situ 
hybridization in the ovary and testis. In the ovary, nanog was found to be 
expressed at a high level in the female germ stem cells oogonia (Figure 5D). A 
weaker signal was also detected in small oocytes (Figure 5E). In the testis, the 
nanog signal is detectable only in spermatogonia (Figure 5F). In both ovary 
and testis, nanog expression is absent in somatic cells (Figure 5D-F).  
I also examined the expression of tcf3 in the testis. The tcf3 signal appears 
moderate in spermatogonia, peaks in spermatocytes and declines in 
spermatids and sperm (Figure 5G). The wide tcf3 expression in various stages 
of spermatogenesis is coincident with its stronger expression in the testis than 
in the ovary, as revealed by RT-PCR analysis (Figure 3). Apparently, tcf3 












Figure 5. RNA expression by in situ hybridization. (A-C) 16-cell embryo after 
two-color in situ hybridization showing nanog (red) and oct4 (green) RNA 
expression. (D-E) Adult ovary after chemical in situ hybridization with a nanog 
riboprobe. (F) Adult testicular section after chemical in situ hybridization with a 
nanog riboprobe. (G) Adult testicular section after fluorescent in situ hybridization 
with a tcf3 probe.  







3.2.4 Expression in ES cell culture 
Finally, I made use of ES cell cultures to validate the candidacy of the seven 
medaka genes as pluripotency markers. I used well characterized medaka ES 
cell lines. MES1 is a diploid ES cell line from fertilization blastulae(Hong et al., 
1996) and capable of chimera formation at high efficacy (Hong et al., 2010; 
Hong et al., 1998). HX1 is a haploid ES cell line from gynogenetic blastulae 
and capable of whole animal production by semicloning(Yi et al., 2009; Yi et al., 
2010a). Both cell lines were maintained under undifferentiated conditions or 
subjected to suspension culture for embryoid body formation to induce 
differentiation(Hong et al., 1996; Yi et al., 2009). Undifferentiated ES cells and 
differentiated samples were analyzed for gene expression by RT-PCR. The 
expression of all the seven genes was high in undifferentiated cultures of both 
ES cell lines but dramatically reduced after 7 days of induced differentiation in 
suspension culture (Figure 6).  
Successful induction of differentiation was evaluated by the expression of no 
tail (ntl), a mesendodermal marker encoding the T-box containing protein 
Brachyury(Araki et al., 2001). In this study, ntl expression was low in ES cells 
before differentiation but high upon differentiation (Figure 6). This result is 
consistent with what has been previously reported (Yi et al., 2009). Therefore, 
all the seven genes appear to be markers for pluripotency in undifferentiated 





Figure 6. RNA expression in ES cell culture(RT-PCR). ES cells were maintained in 
adherent culture for undifferentiated (undiff) growth or in suspension culture for 10 
days for induced differentiation (diff) by formation of embryoid bodies. (A) RT-PCR 
analysis in haploid (HX1) and diploid ES cell line (MES1). The mesendodermal 














3.2.5 Quantitative-PCR analysis of expression in ES cell culture 
To investigate gene expression before and after ES cell differentiation in more 
detail, I analyzed expression of nanog and oct4 by real-time PCR in MES1 
cells. We found that the transcripts of both genes were reduced by ≥4-fold 
(Figure 7), reinforcing that the the seven genes, particularly nanog and oct4, 





















Figure 7. RNA expression in ES cell culture (qPCR).  Real-time RT-PCR analysis of 
Oct4 and Nanog RNA expression. Data are means ± s.d (bars above columns) of 












3.3 Zygotic expression examination 
3.3.1 Gene Cloning in O. celebensis 
In this study, in order to monitor the onset of the zygotic expression of the 
pluripotency genes, I planned to make use of the sequence differences 
between two related species: O. latipes and O. celebensis. Since there is no 
enough information about the sequence of certain genes in the species O. 
celebensis, the first job is to clone certain genes in O. celebensis. Normally, 
degenerate primer should be used in cloning genes in new species. However, 
in order to get enough information about the sequence of certain genes in O. 
celebensis, CDS full length primers from O. latipes were first used. PCR 
results showed positive band in klf4, zfp281a, tcf3, oct4 and nanog. For the 
other two genes, sall4 and ronin, primers at conserved regions were designed. 
The DNA fragments from both species were also successfully amplified 












Figure 8. RT-PCR results of seven genes in O. latipes and O. celebensis 
 
3.3.2 Sequence analysis 
The sequence of those pluripotency genes was analyzed. The sequence 
alignment between O. latipes and O. celebensis was performed (Figure 9-16). 
Among those seven genes, the sequences of nanog, oct4, sall4, klf4, ronin 
and tcf3 show obvious sequence differences which made it possible to design 
the species-specific primer. The regions chose to design species-specific 
primers were marked in Figure 9-16. Only the sequences of the genes zfp281 


























































































3.3.3 RT-PCR analysis using species-specific primer 
To establish embryonic stages at which transcription activation occurs in 
medaka, F1 embryos were obtained by crossing O. celebensis male with O. 
latipes female. By performing RT-PCR using species specific primer, I detected 
the paternal transcripts of the six pluripotency genes (Figure 16). Generally, 
zygotic expression of all these pluripotency genes does not start until early 
blastula, reinforcing that in medaka zygotic expression commences around 
midblastula stage. As can be seen in the zygotic expression pattern of these 
genes, obviously six genes fall into two groups, namely Group A and Group B, 
representing two patterns. In the first pattern including oct4 and nanog (Group 
A), paternal expression could be detected from early blastula. Intensity of 
transcription increased at later stage. In the second pattern (Group B), all other 
five genes showed zygotic expression at late blastula stage, later than group A 
genes.  
On the other hand, another set of F1 embryos were obtained by crossing O. 
latipes male with O. celebensis female. Only the paternal transcripts of Group 
A genes, oct4 and nanog, were examined in those embryos. Similar results 
were obtained. The zygotic expression of both oct4 and nanog started at early 








Figure 16. RT-PCR analysis of zygotic RNA expression in embryos (O. celebensis 
male X O. latipes female).   OL, O. latipes; OC, O. celebensis 
 
Figure 17. RT-PCR analysis of zygotic RNA expression in embryos (O. latipes male 





CHAPTER 4: DISCUSSION 
4.1 Gene identification 
In this study I identified seven medaka homologs/orthologs of mammalian 
pluripotency genes and examined their expression pattern. It has generally 
been accepted that fish has more genes than mammals because of one 
additional genome duplication  event in the common fish lineage after its 
separation ~450 million years ago from the tetrapod lineage leading to birds 
and mammals (Amores et al., 1998). Duplicated fish genes may have different 
functions compared to their single copy gene counterparts in tetrapod 
vertebrates: one gene remains as homolog/ortholog, whereas the other may 
have got lost, or become co-homolog or co-ortholog (by loss of the 
chromosome synteny and original function). Many fish genes are said to be 
mammalian homologs on the basis of sequence comparisons and expression 
patterns. Among these genes in this study, medaka nanog and oct4 have been 
reported to be mammalian homologs (Sánchez Sánchez et al., 2010). In this 
study, a phylogenetic sequence comparison and a conserved syntenic 
relationship along with the expression pattern suggest that the medaka tcf3 
identified in this study is homologous to the mammalian tcf3. However, in the 
absence of syntenic data, it cannot be determined whether the other medaka 
genes are homologous or orthologous to the mammalian counterparts.  
According to the RT-PCR result in adult tissues and embryos, some of these 
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medaka genes show similar RNA expression patterns to those of their mouse 
counterparts, suggesting their homology in expression pattern. 
The gene oct4 is distinguished by exclusive expression in blastomeres, 
pluripotent early embryo cells, and the germ cell lineage (Nichols et al., 1998). 
In mouse blastocyst, oct4 mRNA and protein are present in the ICM but not in 
the trophoblast (Palmieri et al., 1994). In vitro Oct4 is found only in 
undifferentiated embryonal carcinoma (EC), embryonic stem (ES), and 
embryonic germ(EG) cells (Nichols et al., 1998). According to the PCR 
analysis of oct4 in medaka, oct4 showed gonad-specific and early embryo 
expression pattern which is similar to that of mouse oct4.  
In mice, trace amounts of sall4 mRNA were detected in several somatic 
tissues such as the brain, heart and muscle (Tsubooka et al., 2009a), while in 
medaka, the transcripts of sall4 were detected weakly in somatic tissues. In 
both mice and medaka, sall4 is expressed highly in the testis and ovary, 
showing gonad-preferential expression. Meanwhile, sall4 has been found to be 
expressed during early developments in mouse (Yang et al., 2010). Such 
expression pattern is similar to that in medaka early embryos. 
In addition, the expression of tcf3 in medaka is detectable in five somatic 
tissues. Such expression pattern corresponds to the finding that the tcf3 
expression is also not limted to stem cells in mouse (Cole et al., 2008a), 
because Tcf3 is a terminal component of the Wnt pathway which plays multiple 
functions such as body axis specification and morphogenic signaling. 
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On the other hand, difference in the expression pattern of these genes 
between medaka and mouse also exists.  
The mRNA of nanog is present in pluripotent mouse and human cell lines, and 
absent in differentiated cells (Chambers et al., 2003). In mouse, nanog is not 
maternally deposited. Instead its expression commences at the morula stage 
and later on occurs in the ICM, epiblast, PGCs and ES cell cultures, albeit its 
expression is absent in spermatogonia of the adult testis(Cavaleri and Scholer, 
2003; Chambers et al., 2003). This expression pattern is quite different from 
the results in this study, in which nanog is maternally supplied and nanog 
signal is detectable in spermatogonia. So it deserves to note that medaka 
nanog possesses a salient difference in expression in vivo from the mouse 
nanog.  
Second, in this study, it was observed that the medaka klf4 has maternal 
inheritance and early embryonic expression, while in zebrafish expression of 
klf4 in early embryos has also been reported (Luo D, 2011). In mouse, however, 
klf4 lacks expression in early embryos until the blastocyst stage, leading to a 
notion that klf5 might substitute klf4 for blastocyst development (Ema et al., 
2008). Work is needed to determine whether this salient difference in 
embryonic klf4 expression is due to the species difference or independent 
divergence between the fish and tetrapod lineages.  
Furthermore, ronin in mouse was abundantly expressed in two adult tissues: 
ovary and some areas of the brain (Dejosez et al., 2008a). In medaka, ronin 
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shows wide expression pattern in all the adult tissue chosen in this study. 
During early embryonic development, ronin was found to first appear at the 
2-cell stage, intensify during the 8-cell and compact morula stages (Dejosez et 
al., 2008a), suggesting that ronin, like nanog, is also not maternally supplied. 
However, according to the RT-PCR result, ronin is maternally deposited in 
early embryos of medaka.  
4.2 Identification of pluripotency markers 
4.2.1 nanog and oct4 
In the study of mouse, the gene nanog and oct4 are the best studied 
pluripotency genes in ES cell culture. Oct4 and Nanog are thought to be 
central to the transcriptional regulatory hierarchy that specifies ES cell identity 
because of their unique expression patterns and their essential roles during 
early development (Boyer et al., 2005a). 
The PT-PCR analysis shows that the expression patterns of nanog and oct4 in 
adult tissues and embryos are quite similar. Both of them are categorized in 
Group I. According to their RNA expression patterns in adult tissues, nanog 
and oct4 show gonad-specific expression. Then the gene nanog was chosen 
as a representative of group-I genes for in situ hybridization in the ovary and 
testis. From the results in both ovary and testis, nanog expression is high in 
germ stem cells, and absent in somatic cells. Therefore, nanog expression is a 
pluripotency marker in the adult gonads. As for the weak signal of nanog in 
small oocyte, it can be explained by the fact that the oocyte is an exception to 
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differentiated cell, because it expresses pluripotency genes such as oct4 at a 
high level for maternal supply to early embryogenesis(Pesce et al., 1998a). 
The RT-PCR analysis of expression in embryos provides more information. 
The RNAs of nanog and oct4 are maternally supplied, as can been seen from 
the RT-PCR result of the detection of both gene in 16-cell, morula, early 
blastula. The zygotic transcription occurs in MBT. After MBT, the expression of 
both nanog and oct4 sharply declines and ultimately becomes undetectable. 
The midblastula stage in lower vertebrates such as fish is a critical stage for 
pluripotency. At this stage, the embryo is thought to consist of developmentally 
indeterminate cells allowing for ES cell derivation (Hong et al., 1996; Yi et al., 
2009). After the blastula stage, cell lineage restriction and differentiation 
occurs during and after gastrulation. The expression patterns suggest that 
nanog and oct4 appear to be expressed mainly in pluripotent cells of 
developing embryos.  
I also chose 16-cell staged embryo to perform in situ hybridization to detect the 
in vivo expression of nanog and oct4. Both nanog and oct4 were found to be 
present in blastomeres of the 16-cell staged embryo (Figure 5A-C), in 
accordance with a high level of their RNAs by RT-PCR analysis (Figure 4). 
This result is supported by the findings of two other studies. First, the in vivo 
RNA expression pattern of medaka oct4 is similar to what was reported 
(Sánchez Sánchez et al., 2010). Meanwhile, the protein expression of medaka 
nanog detected by immunostaining (Camp et al., 2009) conforms in general to 
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its in vivo RNA expression pattern observed in this study. Since the 
blastomeres at this stage are thought to be totipotent cells in which zygotic 
transcription has not yet commenced, it is possible that both nanog and oct4 
are expressed in totipotent cells.  
Furthermore, in mouse, oct4 and nanog were reported to be down-regulated 
upon ES cells differentiation (Boyer et al., 2005a; Heng and Ng, 2010). In this 
study, RT-PCR analysis and quantitative PCR analysis both provide more 
convincing evidence that the expression level of nanog and oct4 in both ES 
cell line HX1 and MES1 reduced dramatically after differentiation. Once again, 
nanog and oct4 appear to be markers for pluripotency in undifferentiated ES 
cell cultures.  
To sum up, it is revealed in this study that medaka nanog and oct4 expression 
delineates with pluripotency in early embryos, adult gonads and ES cell culture, 
an expression pattern similar to that of the mouse oct4, which shows 
expression throughout the totipotent cycle and ES cells (Pesce et al., 1998a). 
4.2.2 Other genes 
On the other hand, the expression of other five genes, namely klf4, ronin, sall4, 
tcf3 and zfp281 occurs in one or more somatic tissues besides the adult 
gonads and persists beyond gastrulation. These genes in vitro closely 
resemble nanog and oct4, in that they exhibit a high level of expression in 
undifferentiated ES cells and dramatic down-regulation upon ES cell 
differentiation. Similar results have been reported in the studies in mouse. 
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Expression of klf4, ronin, sall4, tcf3 and zfp281 is strongly positive in 
undifferentiated ES cells and less so in differentiated ES cells (Chan et al., 
2009; Dejosez et al., 2008a; Tsubooka et al., 2009b; Wang et al., 2008b; Yi et 
al., 2008). Accordingly, these five genes appear to be also pluripotency 
markers and perhaps even regulators for fish ES cell culture. Obviously, in 
medaka, the lack of pluripotency-specific expression in vitro is not exclusive for 
a gene in question as a pluripotency marker in vivo. A similar situation is also 
seen in mouse, where klf4 exhibits wide expression but is a integral 
component of the four factors capable of reprogramming differentiated cells 
into iPS cells (Takahashi and Yamanaka, 2006).  
Six of the seven medaka genes have previously been found to be expressed 
highly in undifferentiated cultures of two haploid ES cell lines (HX1 and HX2) 
and one diploid MES1 line, and two of them, nanog and oct4 exhibited 
dramatic down-regulation upon haploid ES cell differentiation (Yi et al., 2009). 
The present study corroborates and extends the previous work by 
demonstrating the same pluripotency-specific expression pattern in ES cell 
culture for a set of seven genes including tcf3, a new member identified.  
4.2.3 Somatic expression of pluripotency genes  
By identifying candidate pluripotency genes through the homology approach 
and by examining their expression in vivo and in vitro in this study, I got two 
important findings in medaka. The first is that pluripotency-specific expression 
in vivo is strongly indicative of pluripotency-specific expression also in vitro, as 
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is the case for nanog and oct4. The other is that pluripotency genes do not 
necessarily show pluripotency-specific expression in vivo, as is the case for 
the other five genes.  
According to the RT-PCR analysis of these five genes, which shows that they 
are expressed in one or more somatic tissues besides the adult gonads and 
beyond the gastrulation in embryo development, expression of these genes is 
not restricted to pluripotency in vivo but extended for other processes.  
The finding in the in situ hybridization of tcf3 in the testis provides example for 
such statement. The wide tcf3 expression in various stages of 
spermatogenesis suggests that tcf3 expression in the testis is not limited to 
stem cells but may be important also for additional functions, such as 
spermatogenesis progression. This finding in medaka can be supported by 
other studies in zebrafish wherein both tcf3 genes are required for brain 
patterning (Dorsky et al., 2003; Kim et al., 2000),  
Besides tcf3, other genes can also be found to play function other than 
pluripotency. Klfs family are important in blood vessel development in addition 
to hematopoiesis and epidermal development (Kawahara and Dawid, 2000; 
Suzuki et al., 2005). Klf4 is a pathologically induced factor in endothelial cells 
(ECs) as well as in vascular smooth muscle cells (SMCs) to regulate vascular 
cell function (Suzuki et al., 2005). In addition, the other functions played by 
sall4 are implied by the sall4 mutation disorder, known as Okihiro syndrome,  
which is characterized by limb deformity, eye movement deficits and, less 
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commonly, anorectal, ear, heart, cranial midline and kidney anomalies 
(Tsubooka et al., 2009b). Therefore, many pluripotency genes, such as those 
of groups II and III, appear to be pleiotropic in vivo.  
In this regard, the candidacy for pluripotency genes cannot be determined 
directly according to their in vivo expression pattern. On the other hand, only 
test in ES cell culture showed obvious difference in expression level of these 
genes before and after ES cell differentiation, providing direct evidence that 
these genes are pluripotency markers in undifferentiated ES cell culture. Taken 
together, this study demonstrates that established ES cell culture is a unique in 
vitro system to ultimately test putative pluripotency genes for practical use in 
monitoring the pluripotency of putative ES cells and other stem cell cultures. 
4.2.4 Conserved expression of pluripotency genes in vertebrates 
According to the protein alignment result of those genes, protein products of 
the five genes in expression groups II and III showed substantially high 
sequence conservation while Nanog and Oct4 both exhibited considerable 
divergence in protein sequence. In this study, it is shown that like their 
mammalian counterparts, all the seven medaka genes identified by homology 
search are molecular markers for undifferentiated ES cell culture. These data 
demonstrate that pluripotency genes, in spite of sequence divergence, have 
conserved their pluripotency-specific expression in vitro from mammals to 
lower vertebrates. This notion is supported by previous demonstration that the 
mouse oct4 promoter is active in medaka to drive transgene expression of 
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reporters in early embryos and of drug selectable markers in undifferentiated 
ES cells (Hong et al., 2004b). 
4.3 Zygotic expression pattern 
4.3.1 Zygotic expression at midblastula  
As can be seen from the RT-PCR analysis in embryo, those seven genes in 
this study are all maternally supplied. The activation of zygotic expression of 
those genes cannot be monitored.  
In medaka, by crossing two parental inbred strains, Aizawa made use of 
polymorphism between two strains, to examine the zygotic transcription. For 
gene whose activation begins by the 2 cell stage in mouse embryo, such as 
eif-4c, the zygotic expression of its medaka homolog is activated after stage 11, 
(Aizawa et al., 2003). According to the manifestation of onset of zygotic gene 
expression by Azaiwa, there is no evidence of zygotic expression of EST 
markers before stage 10 (Aizawa et al., 2003). It was concluded that medaka 
MBT in terms of first time transcription of paternal genes begins at stage 11 
(Aizawa et al., 2003). 
In this study, the same method was carried out between two available species, 
O. latipes and O. celebensis. The zygotic expression of several pluripotency 
candidate genes was shown. According to the result, the onset of zygotic 
expression of the gene nanog and oct4 is earlier than stage 11 (late blastula), 
at early blastula stage (stage 10). Meanwhile, it is shown that the other five 
genes are activated at late blastula stage, corresponding to the conclusion in 
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Aizawa’s study.  
The up-regulation of the expression of genes at the MBT has been regarded 
as a sign of the potential developmental roles for certain genes (O'Boyle et al., 
2007). Based on this hypothesis, several important genes which play critical 
roles in embryonic patterning and general cellular metabolism were isolated. 
For example, the activation of apaf1, which is responsible for cell death, and of 
hsp27, which can prevent apoptosis, is key to the balance of apoptosis with 
proliferation. Such balance is crucial in the early embryo for normal 
development to ensue (O'Boyle et al., 2007). Furthermore, in zebrafish, the 
gene klf4, which was also found to be expressed for the first time after the MBT, 
regulates cell growth, proliferation, differentiation and embryogenesis (Dang et 
al., 2000). Klf4 also contributes to blood and vascular development and was 
shown to have a critical role in erythroid cell differentiation in zebraﬁsh 
(Kawahara and Dawid, 2000). In this study, the zygotic expressions of six 
pluripotency genes in this study are activated around MBT, suggesting that 
these genes will play critical roles in later events of embryo development, such 
as gastrulation and segmentation (Bree et al., 2005). Such notion 
corresponded to their roles in maintaining pluripotency and self-renew in ES 
cells. 
Those six genes fall into two groups according to the zygotic expression 
pattern. The group I genes nanog and oct4, which shows pluripotency-specific 
expression, commence their zygotic expression earlier than group II and III 
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genes, which are expressed in other tissues besides gonad and are also 
detectable beyond gastulation. Since the maternal transcript will be exhausted 
at the onset of paternal expression (Aizawa et al., 2003), combining the 
RT-PCR results of both embryos and hybrid embryos, the zygotic expression 
patterns of those genes are inferred (Table 6).  
 
Table 6 Summary of zygotic expression in medaka embryos 
 
Gene 16-cell EM LM EB LB PMG 34som Pre  
nanog - - - + ++ ++ - - 
oct4 - - - + ++ ++ - - 
sall4 - - - - + ++ ++ ++ 
klf4 - - - - + ++ ++ ++ 
ronin - - - - + +++ ++ ++ 
tcf3 - - - - + ++ ++ ++ 
Relative levels of expression are indicated by -, +, ++ and +++ for barely detectable, faintly 
detectable, easily detectable and high expression.  EM, early morula; LM, late morula; 




4.3.2 O. celebensis in building the zygotic expression examining model 
Oryzias celebensis is a medaka related species which inhabits in a tropical 
zone (Hirayama et al., 2006). In the study of molecular phylogeny of the 
medaka fishes genus oryzias, Takehana divided the oryzias species into three 
major species group, namely the latipes, javanicus, and celebensis groups 
(Takehana et al., 2005).  
Previously, the study concerning the zygotic expression of gene has focused 
on two inbred strains within O. latipes (Aizawa et al., 2003). The basis of the 
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study was the polymorphism between different strains. However, if the genes 
do not have obvious polymorphism, the proposed experiment cannot be done. 
O. celebensis is different species from O. latipes, therefore the sequences of 
certain genes show obvious sequence differences between those two species. 
Such hypothesis was confirmed by the sequence obtained in this study. 
O. celebensis is not well studied. Only several studies involving O. celebensis 
were reported, which focused on taxonomic. Although there is no enough 
sequence information about O. celebensis, I can still get the useful data 
through cloning certain genes. According to the sequence analysis of those 
genes between O. latipes and O. celebensis, the sequence differences in 
certain region of the gene sequence makes it possible to design 
species-specific primer. 
The method in this study to examine zygotic expression of certain genes is 
also applicable in other studies.  
4.3.3 Hierarchical expression among pluripotency genes 
ES cells, possess tightly controlled transcriptional regulatory networks that 
maintain the cells in their self-renewing and pluripotent state and poise them 
for differentiation. By DNA microarray and Chromatin Immunoprecipitation 
assay, the transcriptional regulatory network in embryonic stem cells has been 
dissected in mammals (Heng and Ng, 2010).  However, in medaka it has not 
been done. By the method in this study, the hierarchical expression pattern  
which inferred the relationship between those pluripotency genes was 
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obtained （Table 7）.  
 
Table 7. The hierarchy of zygotic activation 
Hierarchy Gene 
Tier I nanog,    oct4 
Tier II sall4,   klf4,   ronin,   tcf3 
 
According to the hierarchy among the pluripotency genes, several facts can be 
related. First, Oct4 and Nanog, along with sox2 form the transcriptional core 
that preserves ES cells self-renewal and pluripotency, regulates and supports 
the pluripotent framework of ES cells by employing regulatory mechanisms 
such as feedforward and autoregulatory loops (Boyer et al., 2005a; Heng and 
Ng, 2010). Particularly, Nanog and Oct4 have been suggested to be important 
for mediating a pluripotent “ground state” in ES cells (Heng and Ng, 2010). 
Furthermore, Oct4 and Nanog were identified to occupy a large number of 
target genes (Boyer et al., 2005a). Their downstream targets are also 
important to keep ES cells from differentiating (Loh et al., 2006a). Taken 
together, the emerging picture is that Oct4 and Nanog control a cascade of 
pathways that are intricately connected to govern pluripotency. Thus, the 
higher hierarchy of zygotic expression of Oct4 and Nanog corresponds to their 
core character within the transcriptional regulatory network in maintaining 
pluripotency of ES cells. 
In addition, it was stated that the expression of genes that are activated at the 
MBT may promote, or be a result of, the dramatic changes in gene expression 
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that occur with the activation of the zygotic genome (O'Boyle et al., 2007). 
Therefore, the hierarchical expression of those genes in this study provides 
clue for their relativity. Since the zygotic expression of nanog and oct4 is 
activated earlier, it is possible that once the decrease and exhaustion of 
maternal transcript occurs, nanog and oct4 are responsible for the zygotic 
activation of other pluripotency genes, including the genes in this study. 
However, those transcription factors do not necessary act on target gene 
independently but work in concert with other factors. The intricate interplay and 
partnership of transcription factors established a complex transcriptional 
network (Heng and Ng, 2010). Anyhow, given the hypothesis based on the 
result in this study, more researches involving the networking of pluripotency 










CHAPTER 5: CONCLUSION AND FUTURE WORK 
5.1 Conclusion 
In this study, I identified seven pluripotency candidate genes by using 
homology approach. By examining their expression in vivo and in vitro in this 
study, those genes were identified as pluripotency markers. This indicates the 
applicability of the homology approach to identify pluripotency genes. The 
seven pluripotency genes and the approach for identifying and testing them as 
pluripotency markers in vitro provide a general tool for testing stem cell 
derivation in other fish species and even other lower vertebrates. 
In addition, a good model was built to examine the timing of zygotic expression 
of the pluripotency genes in developmental embryos. By using this method, I 
examined the paternal transcript of six pluripotency genes. Their activation at 
midblastula transition suggested important roles in embryogenesis. Meanwhile, 
the model to study the zygotic expression of pluripotency genes can be applied 
to the study of other genes, such as germ cell markers namely vasa, boule, 






5.2 Future work 
Following the investigations described in this thesis, a number of projects 
could be taken up:  
 Further investigation and identification of more potential genes that can be 
used as medaka pluripotency markers, such as sox2 and lin28 which are 
used in generation of iPS cells. 
 The detailed roles of the seven genes in maintaining pluripotency are not 
studied. Therefore, studies of gene function are needed, such as gene 
knockout and knockdown.  
 According to the hierarchical expression of the seven genes, it would be 
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